Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis
Objective: Deferasirox is an iron-chelating agent prescribed to patients with iron overload. Due to the interindividual variability of deferasirox responses reported in various populations, this study aims to determine the genetic polymorphisms that influence drug responses.Methods: A systematic sea...
Saved in:
Main Authors: | Kittika Yampayon (Author), Puree Anantachoti (Author), Bunchai Chongmelaxme (Author), Varalee Yodsurang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients
by: Laura Galeotti, et al.
Published: (2021) -
The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases
by: Abuelsoud N, et al.
Published: (2021) -
Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone
by: Paula Soria-Chacartegui, et al.
Published: (2021) -
Efficacy and Side Effects of Deferasirox and Deferiprone for Thalasemia Major in Children
by: Asti Y. Rindarwati, et al.
Published: (2016) -
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder
by: Zastrozhin MS, et al.
Published: (2017)